Development of a Roadmap for the Antimicrobial Usage Monitoring System for Medical Institutions in Korea: a Delphi Study
- Author:
Hyung-Sook KIM
1
;
Se Yoon PARK
;
Heun CHOI
;
Ji Young PARK
;
Mi Suk LEE
;
Byung Wook EUN
;
Hyukmin LEE
;
Jun Yong CHOI
;
Hong Bin KIM
;
Su Jin JEONG
;
Young UH
;
Bongyoung KIM
Author Information
- Publication Type:Original Article
- From:Infection and Chemotherapy 2022;54(3):483-492
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:It is necessary to develop a roadmap for antimicrobial usage monitoring in order to perform monitoring of antimicrobial use at the national level properly. Therefore, this study aimed to develop a roadmap for establishing surveillance and monitoring of antimicrobial use in medical institutions at the national level.
Materials and Methods:A modified Delphi study was conducted, including 3 rounds of an online survey and a virtual meeting with 16 expert panels. The survey items were developed based on a literature review of the surveillance systems for antimicrobial use in 12 countries and interviews with experts. The questionnaire was designed to include both the surveillance and benchmarking systems.
Results:Regarding the scope of target institutions to be included in the surveillance system, medical institutions for sentinel surveillance had the highest proportion of agreement among the panels (75.0%, 9/12). For the benchmarking system, “tertiary- and secondarycare hospitals” were accepted as the scope of target institutions at the current moment.Furthermore, the National Health Insurance claims and prescription data of individual hospitals were considered appropriate data sources for the surveillance system. As for the measures to promote the participation of hospitals in the benchmarking system, “compensation through the establishment of antimicrobial management fees” and “set the participation in the program as a quality evaluation or accreditation index for hospital evaluation” were accepted.
Conclusion:This study provides a roadmap for establishing an antimicrobial use monitoring and benchmarking system for medical institutions at a national level in Korea.
